Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Breast Carcinoma”

728 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 728 results

Not applicableEnded earlyNCT02454777
What this trial is testing

High-Intensity Interval Training for Stage I-III Breast Cancer Patients

Who this might be right for
Stage IA Breast CancerStage IB Breast CancerStage IIA Breast Cancer+4 more
University of Southern California 31
Not applicableWithdrawnNCT05512260
What this trial is testing

Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs

Who this might be right for
Neoplasm, ColorectalNeoplasm, BreastNeoplasm, Ovarian
Karolinska Institutet
Not applicableWithdrawnNCT00329017
What this trial is testing

Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Carol Fabian, MD
Not applicableEnded earlyNCT03560102
What this trial is testing

Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer

Who this might be right for
Breast Cancer, Invasive Ductal
Kantonsspital Winterthur KSW 1
Testing effectiveness (Phase 2)Looking for participantsNCT04954599
What this trial is testing

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Maastricht University Medical Center 126
Testing effectiveness (Phase 2)Ended earlyNCT02806258
What this trial is testing

Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone

Who this might be right for
Radiation Therapy, Breast Cancer, Sequential Partial Breast IrradiationIntermediate and High-risk Luminal and Triple Negative Breast Cancer
University Hospital, Grenoble 362
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07368543
What this trial is testing

Sequencing SG vs. T-DXd in HER2-Low/TROP2-High Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Fudan University 216
Testing effectiveness (Phase 2)Looking for participantsNCT05728268
What this trial is testing

Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index

Who this might be right for
Breast Cancer
Shantou Central Hospital 64
Not applicableStudy completedNCT00347568
What this trial is testing

BC-DAISY: A Breast Cancer Decision Aid System

Who this might be right for
Breast Cancer
Rhode Island Hospital 195
Not applicableStudy completedNCT04999917
What this trial is testing

Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer

Who this might be right for
Breast CancerBreast Cancer InvasiveBreast Cancer in Situ
XEOS Medical 206
Large-scale testing (Phase 3)Not Yet RecruitingNCT07391774
What this trial is testing

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8+2 more
National Cancer Institute (NCI)
Not applicableActive Not RecruitingNCT02103140
What this trial is testing

An Exercise RCT Targeting African-American Women With Metabolic Syndrome and High Risk for Breast Cancer

Who this might be right for
Metabolic SyndromeObesity
Georgetown University 213
Not applicableEnded earlyNCT01188915
What this trial is testing

Personalised Program for Women Treated for Hodgkin Disease

Who this might be right for
Hodgkin DiseaseBreast Cancer
Institut Paoli-Calmettes 51
Not applicableLooking for participantsNCT04265937
What this trial is testing

ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTies

Who this might be right for
Breast CancerGenetic Susceptibility
Fudan University 5,000
Not applicableEnded earlyNCT01096381
What this trial is testing

Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

Who this might be right for
Breast CancerCardiovascular ComplicationsColorectal Cancer+6 more
Vanderbilt-Ingram Cancer Center 8
Not applicableStudy completedNCT00081003
What this trial is testing

Nipple Aspiration, Ductal Lavage, and Duct Endoscopy in Screening Women at Moderate-to-High Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust 1,000
Not applicableLooking for participantsNCT02389673
What this trial is testing

Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast Cancer

Who this might be right for
Breast Neoplasms
Liao Ning 222
Not applicableStudy completedNCT01508273
What this trial is testing

Lifestyle Intervention for High Risk Cancer Survivors

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 1,150
Not applicableNot Yet RecruitingNCT06474975
What this trial is testing

Intra-SURGerY High-resolution Specimen PET/CT Imager for Margin Assessment in Early-stage Breast Cancer

Who this might be right for
Breast CancerBreast-conserving Surgery
European Institute of Oncology 150
Large-scale testing (Phase 3)Active Not RecruitingNCT04622319
What this trial is testing

Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)

Who this might be right for
HER2-Positive Primary Breast CancerResidual Invasive Breast Cancer
Daiichi Sankyo 1,600
Load More Results
1,978